449 total citations 33 papers, 338 citations indexed
About
E Roegel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases.
According to data from OpenAlex, E Roegel has authored 33 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 5 papers in Infectious Diseases. Recurrent topics in E Roegel's work include Sarcoidosis and Beryllium Toxicity Research (7 papers), Antifungal resistance and susceptibility (4 papers) and Occupational exposure and asthma (4 papers). E Roegel is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (7 papers), Antifungal resistance and susceptibility (4 papers) and Occupational exposure and asthma (4 papers). E Roegel collaborates with scholars based in France and Switzerland. E Roegel's co-authors include C. Hirth, M Ehrhart, E Weitzenblum, A. Sautegeau, M Mammosser, Georg Pauli, A Warter, G. Pauli, N Roeslin and Élisabeth Quoix and has published in prestigious journals such as CHEST Journal, Clinical Chemistry and Revue de Pneumologie Clinique.
In The Last Decade
E Roegel
27 papers
receiving
310 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E Roegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Roegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Roegel more than expected).
This network shows the impact of papers produced by E Roegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Roegel. The network helps show where E Roegel may publish in the future.
Co-authorship network of co-authors of E Roegel
This figure shows the co-authorship network connecting the top 25 collaborators of E Roegel.
A scholar is included among the top collaborators of E Roegel based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E Roegel. E Roegel is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Quoix, Élisabeth, et al.. (1991). [Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study].. PubMed. 78(4). 341–6.43 indexed citations
3.
Dietemann-Molard, A, et al.. (1990). [Evaluation of the prognosis in sarcoidosis: remission as an issue of biological criteria and current cellular activities (ACE and alveolar lymphocytosis)].. PubMed. 7(2). 129–34.1 indexed citations
4.
Quoix, Élisabeth, et al.. (1990). [Endobronchial aspergillosis associated with a carcinoid tumor].. PubMed. 7(6). 609–12.12 indexed citations
5.
Kessler, Romain, et al.. (1990). [Pleurisy in ovarian hyperstimulation syndrome. Apropos of a case].. PubMed. 7(6). 599–601.4 indexed citations
6.
Dietemann-Molard, A, Esther Y. Maier, A Pelletier, et al.. (1989). [Multiple elemental organic components of the broncho-alveolar lavage fluid in normal subjects and in various lung pathologies (excluding silica and asbestos fibers)].. PubMed. 6(6). 511–7.2 indexed citations
7.
Boutin, C, E Roegel, B Paramelle, et al.. (1987). Phase II trial of vindesine in malignant pleural mesothelioma.. PubMed. 71(2). 205–6.19 indexed citations
Weitzenblum, E, et al.. (1986). [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].. PubMed. 18(5). 765–73.2 indexed citations
10.
Pauli, G., et al.. (1985). [Invasive aspergillar pneumopathy during the treatment of microcellular bronchial cancer. Efficacy of early antifungal treatment].. PubMed. 2(6). 361–4.1 indexed citations
11.
Roegel, E, et al.. (1984). Sarcoïdes récidivantes sur cicatrices cutanées révélatrices de sarcoïdose thoracique itérative.. Revue de Pneumologie Clinique. 40(2).3 indexed citations
12.
Pauli, G., et al.. (1984). [Clinical aspects of occupational asthma].. PubMed. 40(2). 109–19.8 indexed citations
13.
Roegel, E, et al.. (1984). [Recurrent sarcoidosis in skin scars disclosing repeated thoracic sarcoidosis].. PubMed. 40(2). 81–3.3 indexed citations
14.
Roegel, E, et al.. (1981). [Silicosis with a rapid and pseudo-tumoral course occurring in a case of pre-existant progressive and treated pulmonary sarcoidosis in a miner little exposed to silicosis risk : sarcoido-silicosis (author's transl)].. PubMed. 37(3). 195–202.3 indexed citations
15.
Pauli, G., et al.. (1981). [Pleural effusion as the presenting feature of rheumatoid disease. The value of the level of complement in the pleural fluid. A propos of 2 cases].. PubMed. 37(3). 213–7.1 indexed citations
16.
Roegel, E, et al.. (1972). Variation des prècipitines sèriques anti-Aspergillus fumigatus lors du traitement de l'aspergillose pulmonaire. A propos de 35 cas.. 36(4).1 indexed citations
Roegel, E, et al.. (1971). [Our experience with respiratory aspergillosis (clinical and therapeutic aspects; actual incidence of primary pulmonary aspergillosis; spontaneous course compared with surgical possibilities)].. PubMed. 27(9). 877–901.1 indexed citations
19.
Stoebner, P, et al.. (1970). [Anatomo-clinical study of 10 cases of diffuse pleural mesotheliomas (contribution of electron microscopy)].. PubMed. 24(2). 105–18.1 indexed citations
20.
Roegel, E, et al.. (1966). [Tuberculosis control in the student milieu. Epidemiology, prevention, morbidity. (Experience of the Service de Médicine préventive de l'Université de Strasbourg)].. PubMed. 30(11). 1127–48.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.